- Total
- £46.00
Orforglipron in the UK: availability, price and how to get it
Orforglipron is the generic name of the medicine sold in the UK as Foundayo. This page answers the practical questions: whether it is available here yet, what it costs, who can be prescribed it, and how to buy it without getting caught out.
- Reviewed by Nick Johnson
- Last checked 24 Aug 2026
- Sources linked throughout
The short answer
Orforglipron is available in the UK now. The MHRA authorised it on 10 August 2026 under the brand name Foundayo, making the UK the first country in Europe to approve it. It is a once-daily tablet, it is prescription only, it is not currently on the NHS, and it is bought privately through registered online pharmacies after a clinical consultation. UK prices on the Dayo index currently start from
Is orforglipron available in the UK?
Yes, and it has been since August 2026. Orforglipron reached the UK before the rest of Europe, which is unusual and worth understanding, because a lot of the material you will find online is written from a United States perspective and describes a different regulatory position and different prices.
The UK product is branded Foundayo. Orforglipron is the active ingredient, in the same way that semaglutide is the ingredient inside Wegovy and tirzepatide is the ingredient inside Mounjaro. If you search for one and find pages about the other, they are the same medicine, and any UK pharmacy dispensing it will be dispensing Foundayo.
How much does orforglipron cost in the UK?
There is no single price. Orforglipron is a private purchase, so every pharmacy sets its own, and the spread between the cheapest and the dearest provider for exactly the same tablets is wider than most people expect. Two things drive the number you actually pay:
- Your dose. Treatment runs through six strengths, and cost climbs as you move up. A price quoted for the starting strength tells you very little about what you will pay once you settle.
- What is bundled. Some prices include the consultation and delivery, some do not. A headline that looks lower can end up higher at checkout.
We track both figures continuously: the standard retail price at every dose and the discounted prices after launch offers and codes, each shown as the total cost at checkout with the date we last verified it. If you only read one thing before buying, make it the guide to finding the lowest genuine price, because the cheapest headline and the cheapest year are frequently not the same provider.
Where to buy orforglipron in the UK safely
Orforglipron is prescription only. That means no legitimate UK seller will supply it without a proper clinical assessment, and any site willing to skip that step is breaking the law rather than doing you a favour. The practical route is a General Pharmaceutical Council registered online pharmacy: you complete a medical questionnaire, a prescriber reviews it, and if treatment is appropriate it is dispensed and posted to you.
Before you pay anyone, do the two-minute check. Find the pharmacy's GPhC registration number on its website, look that number up on the official GPhC register, and confirm the registered name and address match the site you are on. Our guide to spotting a fake pharmacy covers the rest of the warning signs, and every provider we list has been through our own verification checks first.
A newly approved weight loss medicine attracts counterfeiters within days. It happened with Mounjaro and with Wegovy, and it is happening here. Treat unusually cheap orforglipron, sales through social media, and anyone offering it without a consultation as red flags rather than bargains.
Who can be prescribed orforglipron in the UK?
The MHRA licensed it for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 alongside at least one weight-related health condition. It is separately licensed to improve blood sugar control in adults with insufficiently controlled type 2 diabetes.
Meeting the BMI threshold is not the same as being suitable for treatment. A prescriber weighs your full medical history, your current medicines and the class warnings before agreeing to anything, and declining is a normal outcome rather than a failure. Our BMI and eligibility guide sets out where the lines fall, including the adjusted thresholds that apply to some ethnic groups.
Is orforglipron on the NHS?
Not at present. MHRA authorisation allows a medicine to be prescribed privately, but NHS availability is a separate decision made by NICE, which assesses cost effectiveness on its own timetable. Until that concludes, orforglipron in the UK is a private prescription only, which is precisely why the price varies so much between pharmacies and why comparing is worth the ten minutes.
How orforglipron differs from the injections
The obvious difference is the format: a daily tablet rather than a weekly injection, with no needles, no sharps bin and no fridge. The less obvious one matters just as much. Orforglipron is a small molecule rather than a peptide, which is why it can be taken at any time of day with no food or water rules, unlike the Wegovy tablet, which requires an empty stomach and a wait before eating.
On results, the published trials put average weight loss lower than tirzepatide's. That trade-off, convenience against maximum effect, is the honest version of the comparison, and it is a conversation for your prescriber rather than a comparison site. We have set out the detail in orforglipron versus Mounjaro and orforglipron versus the Wegovy pill.
Orforglipron UK price at every dose, live
The lowest discounted total on the Dayo index for each of the six strengths, delivery included, regenerated every time this page loads. Treat the middle strengths as the realistic monthly cost, because that is where most people settle.
Best shown prices:0.8mg from £46.002.5mg from £63.005.5mg from £66.009mg from £86.0014.5mg from £114.0017.2mg from £114.00
Prices verified 24 Aug 2026. Ranked strictly by lowest total; no pharmacy can pay for a position. See every pharmacy at every dose.
New Health
Foundayo 0.8mg · Discounted
- Discount price
- £41.00
- Delivery
- £5.00
- Total
- £46.00
- Retail (no discount)
-
£92.00 + £5.00
=
£97.00 - You save
- £51.00 (52.6%)
- Trustpilot
- 4.0 / 5
- GPhC
- 9011199
What has happened since the UK licence
- 10 August 2026
- The MHRA authorises orforglipron as Foundayo for weight management and for type 2 diabetes, the first approval in Europe.
- Late August 2026
- GPhC-registered online pharmacies begin private prescribing; launch offers and codes appear, and prices between providers diverge within days.
- September 2026
- Dayo tracks the tablet at all six strengths across the pharmacies it has verified, re-checking prices within hours of a change. Maintenance policies for people who reach goal weight are confirmed with each pharmacy on the maintenance pharmacies directory.
- Still to come
- A NICE appraisal for NHS use. Until it concludes, orforglipron in the UK is private prescription only, and the NHS route for weight management remains the specialist services already prescribing the injections.
How orforglipron is taken
One tablet, once a day, at whatever time suits you. The UK product information does not require it to be taken on an empty stomach or with a set amount of water, and there is no waiting period before food, which is the practical difference between orforglipron and the semaglutide tablet. That freedom is the main reason people who could not fit the Wegovy pill's morning routine around shift work or an early commute find this one easier to stick with.
Treatment starts at the lowest strength and moves up in steps, with each step held for several weeks before the next. The steps exist to let your stomach adjust, not to test your patience: most of the nausea reported in the trials clustered around the first fortnight and around each increase. The tablets do not need a fridge, so travel and storage are simple; keep them in the original pack and follow the leaflet.
What happens at the consultation
Every legitimate route starts with a questionnaire rather than a basket. You will be asked for your height and weight, your medical history, current medicines, previous weight loss treatment and, at many pharmacies, a photograph to confirm identity and weight. A prescriber, usually a pharmacist independent prescriber and at some services a GMC registered doctor, reviews the answers and may come back with questions before deciding. Approval is not automatic and a refusal is a normal outcome, particularly for a history of pancreatitis, certain thyroid conditions, pregnancy or breastfeeding, or a BMI below the licensed threshold.
Three things are worth doing before you start the form. Weigh yourself properly rather than guessing, because a BMI that sits near a threshold will be checked. List every medicine and supplement you take, because slower stomach emptying can change how some tablets are absorbed. And read the pharmacy's maintenance policy, because the BMI at which a provider stops prescribing matters more than its joining price if you intend to keep the weight off. Our maintenance directory lists the confirmed floors.
Side effects in the first weeks
The honest number is this: in ATTAIN-1, the main 72-week obesity trial, nausea was reported by about a third of people on the two higher doses against roughly one in ten on placebo, and around one in ten on the highest dose stopped treatment because of side effects, against about three in a hundred on placebo. Vomiting, constipation and diarrhoea followed the same pattern. Almost all of it is gastrointestinal, most of it is early, and most of it fades at a stable dose. Our nausea guide covers what helps and the red flags that need a clinician.
Switching from an injection
A meaningful share of the people buying orforglipron in the UK are not new to GLP-1 treatment; they are moving from a weekly injection because they want to be rid of needles, the fridge and the sharps bin. Switching is a prescriber decision, not a checkout option. Your new pharmacy will want to know your current medicine and dose, how long you have been on it and when your last dose was, and will decide where on the tablet's step ladder you start. Do not assume you can jump straight to a high step because you were on a high injection dose. Our switching guide covers timing and evidence.
Orforglipron UK questions
Is orforglipron available in the UK?
Yes. The MHRA authorised orforglipron on 10 August 2026 under the brand name Foundayo, making the UK the first country in Europe to approve it. It is available privately through GPhC registered online pharmacies following a clinical consultation.
What is orforglipron called in the UK?
Foundayo. Orforglipron is the active ingredient and Foundayo is the brand name it is sold under in the UK, in the same way semaglutide is sold as Wegovy and tirzepatide as Mounjaro.
How much does orforglipron cost in the UK?
There is no single price, because it is a private purchase and every pharmacy sets its own. The lowest discounted total on the Dayo index is shown live on this page for each of the six strengths, and the cost rises with the dose you settle at. Compare the total cost at checkout, including consultation and delivery, rather than the headline figure.
Where can I buy orforglipron in the UK?
Through a General Pharmaceutical Council registered online pharmacy, after completing a medical assessment reviewed by a prescriber. Check the pharmacy registration number on the official GPhC register before paying. Any seller supplying it without a consultation is operating unlawfully.
Is orforglipron available on the NHS?
Not at present. MHRA authorisation permits private prescribing, but NHS availability requires a separate NICE assessment which has not yet concluded. Orforglipron is private prescription only for now.
Who can be prescribed orforglipron in the UK?
It is licensed for weight management in adults with a BMI of 30 or above, or 27 to 30 with at least one weight-related condition, and separately for insufficiently controlled type 2 diabetes. Meeting the BMI threshold does not guarantee suitability; a prescriber assesses your full history.
How is orforglipron taken?
As one tablet once a day at any time, with or without food. Unlike the semaglutide tablet it has no empty-stomach or waiting-period rules. Treatment starts at the lowest strength and steps up gradually, and the tablets do not need refrigeration.
Can my GP prescribe orforglipron?
A GP can prescribe it privately if they choose to, but it is not available on an NHS prescription and most GP practices do not offer private weight loss prescribing. In practice almost all UK supply is through registered online pharmacies.
Can I switch from Wegovy or Mounjaro to orforglipron?
Often, but only on a prescriber's decision. The new pharmacy will ask about your current medicine, dose and last injection date and will choose the tablet step you start on. You should not assume you can start at a high step because you were on a high injection dose.
What are the most common side effects of orforglipron?
Gastrointestinal effects. In the ATTAIN-1 trial nausea affected about a third of people on the higher doses, with vomiting, constipation and diarrhoea also more common than on placebo. Most of it occurs early and eases at a stable dose. Severe or persistent abdominal pain needs urgent assessment.
What to read next
If you want the medicine explained properly, including how it works and what the ATTAIN trials actually showed, start with what Foundayo is. If you already know all that and just want the numbers, go straight to the price comparison. For dosing, the six-step guide explains why the strength you start on is not the one you budget for.
Sources and references
- MHRA authorisation announcement — UK licensing status and approved indications
- MHRA Products portal — official product information and patient leaflet
- ATTAIN-1: orforglipron for obesity, New England Journal of Medicine, September 2025 — weight loss, nausea and discontinuation figures quoted above
- GPhC register of pharmacies — checking a pharmacy is registered before you buy
- NICE — NHS availability assessment
- MHRA Yellow Card scheme — reporting suspected side effects or suspicious sellers
Reviewed against primary sources. See our editorial policy for how we source and update content.